Literature DB >> 22980163

Clinical Pearls in breast disease.

Sandhya Pruthi1, John B Bundrick, Scott C Litin.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22980163      PMCID： PMC3498122          DOI： 10.1016/j.mayocp.2012.07.003

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  16 in total

1.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

2.  American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.

Authors:  Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell
Journal:  CA Cancer J Clin       Date:  2007 Mar-Apr       Impact factor: 508.702

3.  Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors:  Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

4.  Incidental treatment of nipple discharge caused by benign intraductal papilloma through diagnostic Mammotome biopsy.

Authors:  M A Dennis; S Parker; T I Kaske; A T Stavros; J Camp
Journal:  AJR Am J Roentgenol       Date:  2000-05       Impact factor: 3.959

Review 5.  Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.

Authors:  Heidi D Nelson; Bernadette Zakher; Amy Cantor; Rongwei Fu; Jessica Griffin; Ellen S O'Meara; Diana S M Buist; Karla Kerlikowske; Nicolien T van Ravesteyn; Amy Trentham-Dietz; Jeanne S Mandelblatt; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2012-05-01       Impact factor: 25.391

6.  Association of breast cancer and its therapy with menopause-related symptoms.

Authors:  Carolyn Crandall; Laura Petersen; Patricia A Ganz; Gail A Greendale
Journal:  Menopause       Date:  2004 Sep-Oct       Impact factor: 2.953

7.  Navigating murky waters: a modern treatment algorithm for nipple discharge.

Authors:  Richard J Gray; Barbara A Pockaj; Patricia J Karstaedt
Journal:  Am J Surg       Date:  2007-12       Impact factor: 2.565

Review 8.  In situ and invasive lobular neoplasia of the breast.

Authors:  A M Hanby; T A Hughes
Journal:  Histopathology       Date:  2008-01       Impact factor: 5.087

9.  HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

Authors:  L Holmberg; H Anderson
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

Review 10.  Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?

Authors:  Mateya Trinkaus; Sheray Chin; Wendy Wolfman; Christine Simmons; Mark Clemons
Journal:  Oncologist       Date:  2008-03
View more
  1 in total

1.  Why case reports matter.

Authors:  Brian J McGrory
Journal:  Arthroplast Today       Date:  2015-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.